Altintas E et al. |
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. |
2004 |
World J. Gastroenterol. |
pmid:15162544
|
Koussoulas V et al. |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. |
2007 |
World J. Gastroenterol. |
pmid:17729416
|
Gumurdulu Y et al. |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. |
2004 |
World J. Gastroenterol. |
pmid:14991935
|
Guo CY et al. |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. |
2004 |
World J. Gastroenterol. |
pmid:14991953
|
Mirbagheri SA et al. |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. |
2006 |
World J. Gastroenterol. |
pmid:16937475
|
Attaran B et al. |
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. |
2017 |
World J. Gastroenterol. |
pmid:28275296
|
Ching SS et al. |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. |
2008 |
World J. Gastroenterol. |
pmid:18609709
|
Miehlke S et al. |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). |
2001 |
World J. Gastroenterol. |
pmid:11819768
|
Sun QJ et al. |
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. |
2010 |
World J. Gastroenterol. |
pmid:20976850
|
Bustamante-Rengifo JA et al. |
In vitro effect of amoxicillin and clarithromycin on the 3' region of cagA gene in Helicobacter pylori isolates. |
2013 |
World J. Gastroenterol. |
pmid:24106405
|
Wang B et al. |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25356059
|
Sargýn M et al. |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. |
2003 |
World J. Gastroenterol. |
pmid:12717872
|
Cianci R et al. |
Third-line rescue therapy for Helicobacter pylori infection. |
2006 |
World J. Gastroenterol. |
pmid:16688818
|
Isomoto H et al. |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15786539
|
Wang HH et al. |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. |
2005 |
World J. Gastroenterol. |
pmid:15786549
|
Wang CH et al. |
Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China. |
2015 |
World J. Gastroenterol. |
pmid:26494972
|
Zhao LJ et al. |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype. |
2014 |
World J. Gastroenterol. |
pmid:24782630
|
Mohammadi M et al. |
Helicobacter pylori antibiotic resistance in Iran. |
2005 |
World J. Gastroenterol. |
pmid:16273615
|
Mabe K et al. |
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? |
2009 |
World J. Gastroenterol. |
pmid:19750572
|
Farshad S et al. |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. |
2010 |
World J. Gastroenterol. |
pmid:21128326
|